Latest News

November 25, 2002
Another menopausal myth is challenged: Women with existing coronary disease do not realize improvement in their cognitive function as a result of taking the most common form of hormone replacement therapy, a UCSF study has found. Investigators followed more than 1000 women from ten US test sites for four years. Half took a placebo; the other half took hormone replacement therapy (HRT). Although other, smaller studies have shown an improvement, in the UCSF study the women who received HRT performed no better on standard tests of cognitive function than those who received placebo.
November 21, 2002
No cases of HIV transmission through unprotected receptive oral sex were found by researchers at UCSF’s Center for AIDS Prevention Studies (CAPS) in a new study.  The study looked at men who have sex with men and who exclusively practice oral sex as the receptive partner.
November 21, 2002
New Clinic at Children's Center at Langley Porter offers help for attention deficit hyperactivity disorder
November 21, 2002
A $2 million grant from the National Institutes of Health to use towards the purchase of the latest in brain-imaging equipment has been received by the San Francisco VA Medical Center. The new high-field MRI/MR spectroscopy system will be the centerpiece of a new center for the imaging of neurodegenerative diseases, including Alzheimer’s disease, epilepsy, post-traumatic stress disorder (PTSD), Gulf War syndrome and more, said Michael Weiner, MD, who will serve as the new center’s director.
November 19, 2002
The University of California, San Francisco co-sponsored a day-long program “I’m Going to College” for more than 125 students and their parents from the E.R. Taylor Elementary School on Wednesday, November 13.
November 19, 2002
In postmenopausal women with coronary disease, neither hormone replacement therapy (HRT) nor antioxidant vitamin supplements provide cardiovascular benefit. In fact, a potential for harm was suggested with each treatment, according to a UCSF-led study. Results from the study, also called the Women’s Angiographic Vitamin and Estrogen (WAVE) trial, appear in the November 20, 2002 issue of the Journal of the American Medical Association (JAMA) and will be presented on November 20, 2002 at the American Heart Association annual meeting in Chicago.
November 18, 2002
UCSF-led scientists have identified the first “master” molecule in the cell nucleus that controls the action of hundreds of different genes at once through its action on enzymes. The broad-acting molecule affects enzymes that restructure chromosomes, exposing genes to proteins that can then trigger key gene processes, including the start of protein production and copying and repairing of genes.
November 18, 2002
Previously secret documents show that tobacco companies provided money, cultivated social and political ties, and aggressively offered free cigarettes to African American leadership groups - even as the evidence grew that African Americans bear a disproportionate share of the tobacco-related disease burden.
November 15, 2002
The University of California, San Francisco, Fresno Medical Education Program’s (UCSF Fresno) Department of Internal Medicine, will present a panel discussion titled, Air Pollution: Is it Killing You? The discussion will take place on Monday, November 18, at 5 p.m. in the UCSF Fresno Rowell Auditorium at the Veteran’s Administration Hospital. It is sponsored by a grant from UCSF Fresno’s Roger K. Larsen, MD, Visiting Professorship Fund.
November 13, 2002
There are serious flaws in the methodology used by the federal government to identify and designate areas with a shortage of oral health care providers and areas of high unmet need, according to a UCSF study.

Pages